Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
e-SPACE Cardio-Renal-Metabolic 2025 – Day One
Author(s): Nisha Bansal, Antonio Ceriello, David Wheeler ,et al Start date: Apr 04, 2025

Heart Failure

Prevention & Chronic Conditions
ESC 24: Hot Line & Late-breaking Science Video Collection
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
What's hot at the ESC Congress 2024?Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen.For a… View more

Intervention

MI/ACS
ACC Congress 2026 Late-Breaking Science Collection
Author(s): Ann Marie Navar Added: 3 weeks ago
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home… View more

Intervention

Vascular Disease and Surgery
Dr Sanjeev Gulati, MD
Research Area(s) / Expertise:
The Cardiology ExpertDr Sanjeev Gulati, MD, is the Enterprise Leader for Heart Failure and Transplant Services at Advocate Health, Charlotte, North Carolina, US. He is board certified in Advanced Heart Failure/Transplant and former Chief of Cardiology at Sanger Heart and Vascular Institute. Prior to his role as Chief of Cardiology, he served as the medical director of the advanced heart failure… View more
Gianluigi Savarese headshot
Research Area(s) / Expertise:

Heart Failure

 Job title: Associate Professor of Cardiology
Gianluigi Savarese is an Italian/Swedish cardiologist, currently Associate Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >400 articles on top peer… View more
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis
Author(s): Added: 5 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview… View more

Heart Failure
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF
Author(s): Barry Borlaug Added: 6 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT… View more

Cardiovascular Kidney Metabolic

Heart Failure
HFSA 2025 Late-Breaking Science Collection
Author(s): Nir Uriel Added: 6 months ago
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Society of America's annual congress, HFSA 2025.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators. View more

Cardiovascular Kidney Metabolic

Guidelines & Statements
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 6 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
IV Iron in Clinical Practice: Experts’ Perspectives
Author(s): Patricia Campbell , Paul Kalra Added: 1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Dr Patricia Campbell and Prof Paul Kalra share their expert perspectives on the use of IV iron in clinical practice. View more

Heart Failure